Transdermally administered scopolamine.
D000287:Administration, Topical; D006801:Humans; D009041:Motion Sickness / Q000188:drug therapy; D011605:Psychoses, Substance-Induced / Q000209:etiology*; D012601:Scopolamine / Q000009:adverse effects* / Q000627:therapeutic use
D012601:Scopolamine